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Abstract
Background: Human Parvovirus B19 (PVB19) has been associated with myocarditis putative due to endothelial infection.
Whether PVB19 infects endothelial cells and causes a modification of endothelial function and inflammation and, thus,
disturbance of microcirculation has not been elucidated and could not be visualized so far.
Methods and Findings: To examine the PVB19-induced endothelial modification, we used green fluorescent protein (GFP)
color reporter gene in the non-structural segment 1 (NS1) of PVB19. NS1-GFP-PVB19 or GFP plasmid as control were
transfected in an endothelial-like cell line (ECV304). The endothelial surface expression of intercellular-adhesion molecule-1
(CD54/ICAM-1) and extracellular matrix metalloproteinase inducer (EMMPRIN/CD147) were evaluated by flow cytometry
after NS-1-GFP or control-GFP transfection. To evaluate platelet adhesion on NS-1 transfected ECs, we performed a dynamic
adhesion assay (flow chamber). NS-1 transfection causes endothelial activation and enhanced expression of ICAM-1 (CD54:
mean6standard deviation: NS1-GFP vs. control-GFP: 85.3611.2 vs. 61.668.1; P,0.05) and induces endothelial expression of
EMMPRIN/CD147 (CD147: mean6SEM: NS1-GFP vs. control-GFP: 114615.3 vs. 8060.91; P,0.05) compared to control-GFP
transfected cells. Dynamic adhesion assays showed that adhesion of platelets is significantly enhanced on NS1 transfected
ECs when compared to control-GFP (P,0.05). The transfection of ECs was verified simultaneously through flow cytometry,
immunofluorescence microscopy and polymerase chain reaction (PCR) analysis.
Conclusions: GFP color reporter gene shows transfection of ECs and may help to visualize NS1-PVB19 induced endothelial
activation and platelet adhesion as well as an enhanced monocyte adhesion directly, providing in vitro evidence of possible
microcirculatory dysfunction in PVB19-induced myocarditis and, thus, myocardial tissue damage.
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Introduction
Human parvovirus B19 (PVB19) has been associated with a
variety of autoimmune diseases such as rheumatoid arthritis,
systemic lupus erythematosus as well as myocarditis, and is found
as the most frequent viral genome of cardiotropic viruses in
endomyocardial biopsies (EMBs) of idiopathic dilated cardiomy-
opathy [1]. PVB19 genome contains a single-stranded linear DNA
and encodes three distinct proteins, non-structural protein
segment 1 (NS1) and two structural viral capsid proteins (VP1
and VP2), which discriminate disease acuity [2]. In particular,
overexpression of NS1 has been found to trigger signaling
cascades, which help promote proapoptotic and apoptotic
processes resulting in anemia, acute fulminant liver failure,
placental insufficiency, and acute and chronic myocarditis [3].
According to a previous case report of a patient with fatal PVB19
myocarditis, an elevated endothelial P-selectin expression demon-
strated endothelial activation [4]. Whether NS1 of PVB19 infects
endothelial cells (ECs) and causes a modification of endothelial
function and inflammation and, thus, disturbance of microcircu-
lation has not been elucidated and could not be visualized so far.
Green fluorescent protein (GFP) is a color reporter gene in NS1,
which has been tested in different experimental settings of various
viral strains such as influenza virus, herpes simplex virus type 1 or
dengue virus-2 [5–8]. Thus, GFP has shown to be an important
screening tool to target implications of different vaccine strategies,
immune modulators, and antiviral compounds [5]. The use of a
GFP gene offers two major advantages. On the one hand, GFP
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luciferase genes, on the other hand, green fluorescent illumination
may be directly, simply, and inexpensively assessed with a
fluorescence microscope [8]. Moreover, visualization of GFP-virus
fusion proteins may help to evaluate live cells and may provide a
clearer view at subnuclear compartments than with immunoflu-
orescent staining [6]. Previous experiments have shown promising
results using GFP to target NS1 of PVB19 in transfected epithelial
cells, which went along with an increased expression and secretion
of proinflammatory cytokine interleukin-6 (IL-6) [9].
However, GFP visualization of pathophysiological processes in
PVB19 transfected ECs is still due.
The aim is to use GFP color reporter gene in NS1 of PVB19 to
show transfection and, thus, visualize pathophysiological patterns
of myocarditis in concert with markers of transfected EC
expression, monocyte as well as platelet rolling and adhesion.
Materials and Methods
Transfection of ECs with Green Fluorescent Protein-NS1-
PVB19
To examine the PVB19-induced endothelial modification, we
transfected an endothelial-like cell line ECV304 (Cell Lines Service,
Eppelheim, Germany) using Lipofectamine 2000 as a transfection
reagent (Invitrogen, Karlsruhe, Germany). Transfected ECV304
was grown in Medium199 (Invitrogen, Karlsruhe, Germany) and
supplemented with 4% fetal calf serum (FCS) and 2% penicillin,/
streptomycin, L-glutamine. Transfection was performed with
PVB19 nonstructural protein NS-1 plasmid (NS-1 pEGFP-C1) or
control plasmid (pEGFP-C1) using 2 mg of each plasmid (Clontech,
Mountain View, CA, USA), as described earlier [9]. A sketch of the
virus with its three distinct proteins, non-structural protein segment
1 (NS1) and two structural viral capsid proteins (VP1 and VP2), and
thebindingofgreenfluorescentprotein(GFP)colorreportergeneto
NS1, which was friendly provided by Prof. Gregory Tsay, Taiwan,
is given in Figure 1A.
The transfection was verified through flow cytometry (see
below), immunofluorescence microscopy (Axiovert 200, Carl Zeiss
GmbH, Go ¨ttingen, Germany) and real-time polymerase chain
reaction (RT-PCR) analysis, which was analyzed according to
previous description [9,10]. In brief, total RNA was isolated from
ECs using an RT-PCR Kit reagent (Qiagen, Hilden, Germany)
with PVB19 NS1 primers B19 NS1 sense nucleotides (59-
ATGGAGCTATTTAGAGGG-39) and B19 NS1 anti-sense
nucleotides (59-AAGTAGCACAAATACAGGT-39) and glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) primers GAPDH
sense nucleotides (59-CATGTTCGTCATGGGTGTGA-39) and
GPDA anti-sense nucleotides (59-AGTGAGCTTCCCGTT-
CAGCTC-39) according to a standard protocol.
Flow Cytometry (FACS)
The priniciple of flow cytometric analysis has been performed to
a standard protocol and has been described previously for
endothelial surface expression of intercellular-adhesion molecule-1
Figure 1. Green Fluorescent Protein to Visualize Transfection of an Endothelial-like Cell Line (ECV304) by NS1-Parvovirus B19
(PVB19). (A) Sketch of the parvovirus B19 (PVB19) plasmid with its three distinct proteins, non-structural protein segment 1 (NS1) and two structural
viral capsid proteins VP1 and VP2, as well as the binding of green fluorescent protein (GFP) color reporter gene to NS1. (B) The transfection of
endothelial cells (ECs) was verified simultaneously through flow cytometry, immunofluorescence microscopy and real-time polymerase chain reaction
(RT-PCR) analysis after 24, 48, 72, and 96 h. The transfection rate (%) at the subsequent timepoints decreased in NS1-GFP transfected EC faster than in
the GFP-control.
doi:10.1371/journal.pone.0033602.g001
Green Fluorescent Protein NS1-PVB19 Transfection
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ducer ‘‘EMMPRIN’’ (EMMPRIN/CD147) [11,12]. In brief,
ECV304 were incubated with 5 mg/mL of either monoclonal
anti-ICAM (Cymbus Biotechnology, Hants, United Kingdom),
anti-Cyclophilin A, or anti-EMMPRIN/CD147 (clone1G6.2) for
60 min at 4uC in the dark. Then, cells were washed twice with
RPMI1640 mediumcontaining2%FCSand analyzed.Allanalyses
were performed on a FACScan flow cytometer (Becton Dickinson,
Heidelberg, Germany) using CellQuest software. Mean fluores-
cence intensity (MFI) was used as index of receptor expression.
IgG1-FITC (fluorescein isothiocyanate) was used as isotype control.
Flow Chamber
To evaluate platelet adhesion on NS-1 transfected ECs, we
performed a dynamic adhesion assay as previously described [10].
In brief, EC cultivation was performed on glass cover slips until
they reached confluence, activated with tumor necrosis factor-a
(TNF-a; 50 ng/mL) as well as interferon-c (IFN-c; 20 ng/mL) for
12 h, and used in a flow chamber (Oligene, Berlin, Germany). The
principle of isolation of cells (platelets and monocytes) has been
described earlier [11,12]. Isolated platelets (2610
8/mL) were
perfused over the EC monolayer at shear rates of 2000 s
21 (high
shear stress). All experiments were recorded with a real-time
camera and evaluated off-line. The number of adherent cells were
assessed for high powerfield (hpf).
Statistical Analysis
Values are presented as mean6standard deviation (SD). A
probability value of less than 0.05 was considered as statistically
significant and has been evaluated with the unpaired Student’s T-test.
All statistical analyses were performed using PASW Statistics software
for Windows Version 18.0, 2009 (IBM SPSS Inc., Chigaco, IL, USA).
Results
The transfection of ECs was verified simultaneously through
flow cytometry, immunofluorescence microscopy and RT-PCR
analysis after 24, 48, 72, and 96 h (Figure 1B). The transfection rate
(%) at the subsequent timepoints decreased in NS1-GFP
transfected EC faster (24 h: 29.67%; 48 h: 15.43%; 72 h:
7.98%; 96 h: 3.94%) than in the GFP-control (24 h: 57.59%;
48 h: 42.50%; 72 h: 35.89%; 96 h: 28.76%).
Visualized by GFP, NS-1 transfection causes endothelial activation
and enhanced expression of ICAM-1 (CD54: mean6SD: NS1-GFP
vs. control-GFP: 85.3611.2 vs. 61.668.1; P,0.05) (Figure 2A),a n d
induces endothelial expression of EMMPRIN/CD147 (CD147 :
mean6SEM: NS1-GFP vs. control-GFP: 114616.5 vs. 8063.1;
P,0.05) compared to control-GFP transfected cells (Figure 2B).
Dynamic adhesion assays (flow chamber) showed that adhesion
of platelets was enhanced twice as much on NS1 transfected ECs
compared to control-GFP (NS1-GFP vs. control-GFP: 1263.7/
hpf vs. 661.4/hpf; P,0.05) (Figure 2C). Similar results were found
with the number of adherent monocytes, which were significantly
enhanced on NS1 transfected ECs compared to control-GFP
(NS1-GFP vs. control-GFP: 1262.9/hpf vs. 660.8/hpf; P,0.05)
(Figure 2D). Figure E shows distinctive examples of ECs represen-
tative for NS1-GFP, GFP-control, TNF-a/IFN-c stimulated cells
and resting cells 24 h after transfection.
Figure 2. Green Fluorescent Protein NS1 Transfection Induces Endothelial Activation and Platelet Adhesion. (A) Non-structural protein
segment 1 (NS1) transfection of endothelial cells visualized by green fluorescent protein (GFP) causes endothelial activation and enhanced expression
of ICAM-1/CD54 and (B) induces endothelial expression of EMMPRIN/CD147 compared to control-GFP transfected cells. (C) Dynamic adhesion assays
(flow chamber) showed that adhesion of platelets was enhanced twice as much on NS1 transfected ECs compared to control-GFP. (D) Similar results
were found with the number of adherent monocytes. (E) Distinctive images of ECs representative for NS1-GFP, GFP-control, TNF-a/IFN-c stimulated
cells and resting cells 24 h after transfection. *denotes stastical significance (P,0.05). Whiskers represent standard deviation.
doi:10.1371/journal.pone.0033602.g002
Green Fluorescent Protein NS1-PVB19 Transfection
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The major findings of this study are that 1) GFP visualizes
PVB19-NS1 induced transfection of ECs, which causes endothelial
activation and enhanced expression of ICAM-1/CD54 and
endothelial expression of EMMPRIN/CD147 compared to
control-GFP transfected cells; 2) dynamic adhesion assays (flow
chamber) showed that adhesion of platelets is significantly
enhanced on NS1 transfected ECs when compared to control-
GFP; 3) similar results were found with an enhanced number of
adherent monocytes after NS1 transfection.
The pathophysiological mechanisms of many viruses still remain
obscure and visualization of the pathogenic processes is limited. In
particular, the underlying cause of myocarditis consists of a
remarkable number of infectious and non-infectious agents, which
cannot be identified and where the exact cardiac site of infection
are unknown [13]. Human PVB19 is ascribed a predominant role
in all cardiotropic viruses [1], and PVB19-induced endothelial
dysfunction contributes significantly to the pathomechanism of
diastolic dysfunction [14]. However, due to the incongruity
between clinical and histological features derived from EMB
samples of patients with PVB19 myocarditis, alternative diagnostic
approaches are eligible to establish the infectious origin of the
disease [15].
Human PVB19 has been characterized with three distinct
genotypes, open reading frames, which encode NS1 and two
structural proteins [16]. Among these, NS1 has shown to play a
crucial role in pathogenic processes [3]. Due to NS1 transactivator
functions (protein overexpression) of PVB19, the virus may switch
on a variety of cellular genes including immunomodulatory IL-6
[10], which may lead to autoaggressive reactions with profound
cytosolic acidification and subsequent [3]. In the present study, we
found that NS1 transfected ECs are modified reflecting changes
and partly disruption of endothelial function and microcirculation.
The simple and rapid readout of a GFP-virus assay is considered
as a beneficial aspect of the methodology [17]. However, it should
be taken into account that the absolute number and the intensity
of green cells are known to be variable, but the relative activity of
various transfected targets are consistent between experiments
[17]. As decribed earlier in a different setting of influenza virus
expressing GFP from the NS1 reading frame, the GFP insert may
have resulted with a negative impact on the formation of NS1 [7].
However, although our transfection rates decreased faster in the
NS1-GFP transfected ECs compared to GFP-control suggesting a
higher stability in the GFP-control assay, the transfection rates for
NS1-GFP 24 h and 48 h after EC transfection remained on an
enhanced level (Figure 1B). However, based on results from
preliminary experiments, we found a higher transfection rate in
ECV304 compared to human umbilical vein endothelial cells
(HUVEC) (data not shown).
Previous experiments using GFP to visualize NS1 PVB19
transfection in epithelial cells found an enhanced inflammatory
response with a high expression and secretion of IL-6 [9]. Thus,
NS1 PVB19 inflammatory signaling modulation activates signal
transducers and activators of transcription 3 (STAT3) [10], which
induce an enhanced ICAM1 expression [18]. These findings are in
the line with our present experiments, which provided in vitro
evidence of PVB19-NS1 induced endothelial expression (CD54/
ICAM-1) and extracellular matrix metalloproteinase activation
(EMMPRIM/CD147).
Our group recently showed that EMMPRIM along with its
ligand cyclophilin A share diagnostic biomarker functions in
patients with inflammatory cardiomyopathy/myocarditis. Thus,
further experiments with GFP should preferably focus on in vivo
targets.
Previous studies on viral disease showed that GFP may be useful
to visualize therapeutic effects (vaccines, immune modulators,
antiviral agents) [5]. In PVB19-myocarditis, there is a lack of
pathway-specific treatment [19], thus, a GFP-guided visualization
of pathogenic processes may attribute to novel therapeutic
applications. Over the last years, the idea of therapeutic
immunosuppression has been left in favor of immunomodulation
using proinflammatory cytokines, which shall help to eliminate
virus from the myocardium [20]. To date, interferon-b (INF-b) has
been considered as a rather promising agent, which was tested in
patients with myocardial persistence of viral genome [21].
However, frequently flu-like side-effects of the drug did not help
to establish its clinical use so far. Thus, another therapeutical
approach of PVB19 myocarditis has recently been discussed
targeting chemokine receptor of fractalkine (CX3CL1) [22]. Based
on CX3CL1-mediated chemotactic and adhesive properties, it
may be tempting to speculate that effects of cardiac and plasmatic
fractalkines may be visualized similarly to our present findings
using a GFP-guided NS1-PVB19 transfection.
In conclusion, use of green fluorescent protein (GFP) color
reporter gene visualizes transfection of endothelial-like cell line
(ECV304) and, thus, may help to parvovirus B19 (PVB19)
nonstructural-protein (NS1) induced endothelial activation and
platelet adhesion as well as an enhanced monocyte adhesion
directly, providing in vitro evidence of possible microcirculatory
dysfunction in PVB19-induced myocarditis and reactive damage
of the myocytes.
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